Analytical Data
-
基因名
CCDC60
- Application
-
别名
CCDC60;CAZIP;KIAA0774;TIP150;Microtubule-associated tumor suppressor candidate 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8IWA6
-
表达区间
1-550aa
-
氨基酸序列
MTKVPATKKL QSSPNSGAVR PFYASENLRQ VPDKPMKSIK YMDKEIINLK KDLIRSRFLI QSVKIGRGYF AILREETAKK KKQQQLQKLK EEERNKFQPA EKISEIHYGD TLLSTYDDEK LKTLGARVTR RPFTPIHSCI ISPSLTEAHV EPLFRQLCAL HWLLEALTID HTHHTMKPVI TCWNPKDPGG SKSTIKKINK DKSMGQKWEH FITAPKTKKF KIPTMRVTNR KPSRRGSTLS LSRASGGSSP QSSMISVNPG SDEPPSVNTQ VTSSKDIEDN ESSSTKPDEE PLYMNLQKLL EMVREDARRT VTIENGMQRK APSILSVLKQ NKSNSAYKEM QTTLKSSERS SSTSAESHIQ PVQKKSKNRT NCDINIHYKS GVCNTMRAKF YSVAQEAGFC LQDKMEILMK RQEERGIQKF RAFVLVSNFQ KDIAKMRHHI SVVKGDAEEI ADHWYFDLLS KLPEDLKNFR PAKKILVKLQ KFGENLDLRI RPHVLLKVLQ DLRIWELCSP DIAVAIEFVR EHIIHMPQED YISWLQSRIN IPIGPYSALR
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCDC60, or Coiled-Coil Domain Containing 60, is a protein that has garnered attention due to its potential roles in various cellular processes, including cell cycle regulation, apoptosis, and protein-protein interactions. Its coiled-coil structure suggests a capacity for oligomerization, which may be crucial for its functions in cellular signaling pathways. Recent studies have indicated that alterations in CCDC60 expression can be associated with several pathologies, including cancer and neurodegenerative disorders, highlighting its potential as a biomarker or therapeutic target. The recombinant production of CCDC60 protein allows researchers to explore its biochemical properties, interactions with other cellular components, and its role in disease mechanisms. By studying the recombinant CCDC60, scientists aim to elucidate its specific functions and how it contributes to the maintenance of cellular homeostasis. This research could pave the way for new insights into therapeutic strategies that target CCDC60-related pathways, advancing our understanding of complex disease processes. As such, the investigation of CCDC60 not only enhances the fundamental knowledge of protein function but also holds promise for the development of innovative treatments in the future.












